T. Barrett, S. Wilhite, P. Ledoux, C. Evangelista, I. Kim et al., NCBI GEO: archive for functional genomics data sets--update, Nucleic Acids Research, vol.41, issue.D1, pp.991-996, 2013.
DOI : 10.1093/nar/gks1193
URL : http://doi.org/10.1093/nar/gks1193

N. Kolesnikov, E. Hastings, M. Keays, O. Melnichuk, Y. Tang et al., ArrayExpress update--simplifying data submissions, Nucleic Acids Research, vol.43, issue.D1, pp.1113-1129, 2015.
DOI : 10.1093/nar/gku1057
URL : http://doi.org/10.1093/nar/gku1057

C. Kandoth, M. Mclellan, F. Vandin, K. Ye, B. Niu et al., Mutational landscape and significance across 12 major cancer types, Nature, vol.339, issue.7471, pp.333-342, 2013.
DOI : 10.1126/science.1235122
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3927368

J. Zhang, J. Baran, A. Cros, J. Guberman, S. Haider et al., International Cancer Genome Consortium Data Portal--a one-stop shop for cancer genomics data, Database, vol.2011, issue.0, p.26, 2011.
DOI : 10.1093/database/bar026
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263593

L. Alexandrov, S. Nik-zainal, D. Wedge, S. Aparicio, S. Behjati et al., Signatures of mutational processes in human cancer, Nature, vol.27, issue.7463, pp.415-436, 2013.
DOI : 10.1093/bioinformatics/btr354

S. Nik-zainal, H. Davies, J. Staaf, M. Ramakrishna, D. Glodzik et al., Landscape of somatic mutations in 560 breast cancer whole-genome sequences, Nature, vol.14, issue.7605, pp.47-54, 2016.
DOI : 10.1093/bioinformatics/btq170
URL : https://hal.archives-ouvertes.fr/hal-01388447

A. Ferrari, A whole-genome sequence and transcriptome perspective on HER2-positive breast cancers, Nature Communications, vol.3, p.12222, 2016.
DOI : 10.1007/BF00994134
URL : https://hal.archives-ouvertes.fr/hal-01388446

P. Jiang and X. Liu, Big data mining yields novel insights on cancer, Nature Genetics, vol.47, issue.2, pp.103-107, 2015.
DOI : 10.1038/nmeth.1772

E. Cerami, J. Gao, U. Dogrusoz, B. Gross, S. Sumer et al., The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1., Cancer Discovery, vol.2, issue.5, pp.401-405, 2012.
DOI : 10.1158/2159-8290.CD-12-0095

J. Gao, B. Aksoy, U. Dogrusoz, G. Dresdner, B. Gross et al., Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal, Science Signaling, vol.26, issue.18, p.1, 2013.
DOI : 10.1093/bioinformatics/btq430

H. Lee, J. Palm, S. Grimes, and H. Ji, The Cancer Genome Atlas Clinical Explorer: a web and mobile interface for identifying clinical???genomic driver associations, Genome Medicine, vol.155, issue.Suppl 6, p.112, 2015.
DOI : 10.1016/j.cell.2013.09.034

Y. Wan, G. Allen, and Z. Liu, TCGA2STAT: simple TCGA data access for integrated statistical analysis in R, Bioinformatics, vol.32, issue.6, pp.952-956, 2016.
DOI : 10.1093/bioinformatics/btv677

C. Curtis, S. Shah, S. Chin, G. Turashvili, O. Rueda et al., The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups, Nature, vol.452, issue.7403, pp.346-52, 2012.
DOI : 10.1038/nature06757

J. Guinney, R. Dienstmann, X. Wang, A. De-reynies, A. Schlicker et al., The consensus molecular subtypes of colorectal cancer, Nature Medicine, vol.228, issue.11, pp.1350-1356, 2015.
DOI : 10.1186/gb-2004-5-10-r80

P. Bunn-jr, W. Franklin, and R. Doebele, The Evolution of Tumor Classification: A Role for Genomics?, Cancer Cell, vol.24, issue.6, pp.693-697, 2013.
DOI : 10.1016/j.ccr.2013.11.019

C. Lung-cancer-genome, P. , N. Genomic, and M. , A genomics-based classification of human lung tumors, Sci Transl Med, vol.5, issue.209, pp.209-153, 2013.

C. Genome-atlas-research, N. Weinstein, J. Collisson, E. Mills, G. Shaw et al., The Cancer Genome Atlas Pan-Cancer analysis project, Nat Genet, vol.45, issue.10, pp.1113-1133, 2013.

M. Iglesia, J. Parker, K. Hoadley, J. Serody, C. Perou et al., Genomic Analysis of Immune Cell Infiltrates Across 11 Tumor Types, Journal of the National Cancer Institute, vol.108, issue.11, 2016.
DOI : 10.1093/jnci/djw144

A. Newman, C. Liu, M. Green, A. Gentles, W. Feng et al., Robust enumeration of cell subsets from tissue expression profiles, Nature Methods, vol.9, issue.5, pp.453-460, 2015.
DOI : 10.1038/sj.gene.6364173

P. Nowell, The clonal evolution of tumor cell populations, Science, vol.194, issue.4260, pp.23-31, 1976.
DOI : 10.1126/science.959840

M. Greaves and C. Maley, Clonal evolution in cancer, Nature, vol.69, issue.7381, pp.306-319, 2012.
DOI : 10.1158/0008-5472.CAN-08-3658
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3367003

C. Swanton, Intratumor Heterogeneity: Evolution through Space and Time, Cancer Research, vol.72, issue.19, pp.4875-82, 2012.
DOI : 10.1158/0008-5472.CAN-12-2217
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712191

M. Gerlinger, A. Rowan, S. Horswell, J. Larkin, D. Endesfelder et al., Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing, New England Journal of Medicine, vol.366, issue.10, pp.883-92, 2012.
DOI : 10.1056/NEJMoa1113205

L. Ding, T. Ley, D. Larson, C. Miller, D. Koboldt et al., Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing, Nature, vol.115, issue.7382, pp.506-516, 2012.
DOI : 10.1182/blood-2009-11-254284
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3267864

C. Roche-lestienne, J. Lai, S. Darre, T. Facon, and C. Preudhomme, A Mutation Conferring Resistance to Imatinib at the Time of Diagnosis of Chronic Myelogenous Leukemia, New England Journal of Medicine, vol.348, issue.22, pp.2265-2271, 2003.
DOI : 10.1056/NEJMc035089

R. Fisher, L. Pusztai, and C. Swanton, Cancer heterogeneity: implications for targeted therapeutics, British Journal of Cancer, vol.25, issue.3, pp.479-85, 2013.
DOI : 10.1126/scitranslmed.3003854
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3593543

E. Heitzer, M. Auer, C. Gasch, M. Pichler, P. Ulz et al., Complex Tumor Genomes Inferred from Single Circulating Tumor Cells by Array-CGH and Next-Generation Sequencing, Cancer Research, vol.73, issue.10, pp.2965-75, 2013.
DOI : 10.1158/0008-5472.CAN-12-4140

Y. Lo and R. Chiu, Plasma nucleic acid analysis by massively parallel sequencing: pathological insights and diagnostic implications, The Journal of Pathology, vol.37, issue.3, pp.318-341, 2011.
DOI : 10.1093/nar/gkn963

C. Ip, M. Loose, J. Tyson, M. De-cesare, B. Brown et al., MinION Analysis and Reference Consortium: Phase 1 data release and analysis, F1000Research, vol.4, p.1075, 2015.
DOI : 10.12688/f1000research.7201.1
URL : http://doi.org/10.12688/f1000research.7201.1

J. Blay, O. Tredan, I. Ray-coquard, M. Rivoire, P. Mehlen et al., Fifteen important questions for oncology to be addressed from 2015, Bulletin du Cancer, vol.102, issue.6, pp.22-28, 2015.
DOI : 10.1016/S0007-4551(15)31214-5

L. Tourneau, C. Delord, J. Goncalves, A. Gavoille, C. Dubot et al., Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial, The Lancet Oncology, vol.16, issue.13, pp.1324-1358, 2015.
DOI : 10.1016/S1470-2045(15)00188-6

B. Kuehn, Alliance Aims for Standardized, Shareable Genomic Data, JAMA, vol.310, issue.3, pp.248-257, 2013.
DOI : 10.1001/jama.2013.8327

S. Rose, Huge data-sharing project launched, Cancer Discov, vol.6, issue.1, pp.4-5, 2016.